{"disease":{"id":"waldenstrom-s-disease","name":"waldenstrom s disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00039676","title":"Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1836,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT01804686","title":"A Long-term Extension Study of PCI-32765 (Ibrutinib)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT05911802","title":"Prognostic Analyses on a Validation Series of Patients With Waldenström's Disease","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"French Innovative Leukemia Organisation","has_results":false},{"nct_id":"NCT03329950","title":"A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":132,"lead_sponsor_name":"Celldex Therapeutics","has_results":false},{"nct_id":"NCT06712810","title":"Q702 for the Treatment of Patients With Hematologic Malignancies","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":46,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT03952052","title":"Detection of Recurrent Mutations in Waldenström's Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Centre Henri Becquerel","has_results":false},{"nct_id":"NCT03679624","title":"Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":true}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}